Financial Statements — CBLL
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 |
|---|
| Cash & Equivalents | 45.25 | 23.74 | 40.14 | 153.36 | 14.11 |
| Short-term Investments | 95.93 | 144.80 | 137.29 | 29.34 | -- |
| Accounts Receivable | 15.71 | 12.23 | 12.31 | 11.30 | 9.97 |
| Inventory | 6.90 | 6.02 | 6.00 | 6.55 | 6.91 |
| Total Current Assets | 168.91 | 191.81 | 199.79 | 205.42 | 34.96 |
| Property, Plant & Equipment | 1.93 | 2.06 | 2.11 | 2.13 | 2.27 |
| Total Non-current Assets* | 9.17 | 7.72 | 7.90 | 8.05 | 12.10 |
| Total Assets | 178.08 | 199.53 | 207.69 | 213.47 | 47.06 |
| Accounts Payable | 1.98 | 2.18 | 2.44 | 1.37 | 2.78 |
| Total Current Liabilities | 16.18 | 15.17 | 15.01 | 11.83 | 13.09 |
| Total Non-current Liabilities | 21.08 | 20.28 | 20.52 | 20.76 | 22.54 |
| Total Liabilities | 37.27 | 35.44 | 35.53 | 32.59 | 35.63 |
| Retained Earnings | (240.09) | (206.83) | (193.36) | (179.72) | (154.37) |
| Total Stockholder Equity | 140.81 | 164.08 | 172.16 | 180.88 | (135.98) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 |
|---|
| Total Revenue | 26.49 | 24.78 | 22.59 | 21.20 | 20.49 | 18.53 | 17.20 |
| Cost of Revenue | 3.37 | 3.14 | 2.65 | 2.52 | 2.48 | 2.30 | 2.18 |
| Gross Profit | 23.12 | 21.64 | 19.94 | 18.68 | 18.01 | 16.24 | 15.01 |
| Research & Development | 6.16 | 5.06 | 4.98 | 4.85 | 4.25 | 3.91 | 3.40 |
| Selling, General & Admin | 15.32 | 12.12 | 11.04 | 11.36 | 9.94 | 9.97 | 9.03 |
| Total Operating Expenses | 43.87 | 36.24 | 34.59 | 33.63 | 32.21 | 29.12 | 24.95 |
| Operating Income | (20.74) | (14.60) | (14.65) | (14.95) | (14.21) | (12.88) | (9.94) |
| Pretax Income | (19.74) | (13.53) | (13.46) | (13.64) | (12.78) | (12.58) | (10.42) |
| Tax Provision | -- | -- | -- | -- | -- | -- | 0.01 |
| Net Income | (19.74) | (13.53) | (13.46) | (13.64) | (12.78) | (12.58) | (10.42) |
| Basic EPS | (0.52) | (0.35) | (0.37) | (0.38) | (0.36) | 1.63 | (1.85) |
| Diluted EPS | (0.52) | (0.35) | (0.37) | (0.38) | (0.36) | 1.63 | (1.85) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 |
|---|
| Operating Cash Flow | (19.30) | (10.77) | (11.10) | (7.53) | (11.40) | (9.97) | (25.07) |
| Capital Expenditures | 0.13 | 0.18 | 0.37 | 0.07 | 0.15 | 0.36 | 0.98 |
| Free Cash Flow* | (19.42) | (10.95) | (11.47) | (7.60) | (11.55) | (10.33) | (26.05) |
| Investing Cash Flow | 22.44 | 26.11 | (6.94) | (107.69) | (29.61) | (0.49) | (1.10) |
| Financing Cash Flow | 1.63 | 1.40 | 1.64 | 2.01 | 0.00 | 190.73 | 5.79 |
* Derived from reported values
